Post-earnings recap
Reported
Tue, Jul 28, 2026
EPS actual
$3.15
EPS est.
$2.72
EPS surprise
+15.72%
1-day move
+13.94%
Despite missing EPS expectations, IQVIA's stock rose by nearly 14%, indicating investor optimism. The strong stock reaction may reflect confidence in the company's future performance, even without specific revenue figures or guidance updates. The substantial EPS surprise suggests that the company managed to control costs effectively, which could bode well for future quarters.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.15 | $3.27 | +15.72% |
| Revenue | N/A | $4.4B | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
IQVIA Holdings Inc. operates in the health care sector, providing data analytics and technology solutions to life sciences companies. With a focus on improving patient outcomes and enhancing operational efficiency, IQVIA plays a crucial role in the evolving landscape of health care and pharmaceutical research.
Last quarter
In Q1-2026, IQVIA reported an EPS of $2.90, exceeding analyst expectations by 15.68%. The stock reacted positively, gaining 9.62% the following day.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+12.20%
Avg 1-day reaction
+3.07%
Analysts are generally optimistic about IQVIA's upcoming earnings, expecting strong performance based on recent trends. The consensus EPS estimate reflects confidence in the company's growth trajectory.
Bull case
If IQVIA beats EPS expectations and shows strong revenue growth, it could signal robust demand for its services, leading to a positive market reaction.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and lead to a significant stock decline.
Key metrics to watch
EPS
$3.27Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$4.4BTotal revenue reflects the company's ability to grow its business and capture market share in the competitive life sciences industry.
The print will turn on these.
Q1
Will IQVIA's EPS exceed the consensus estimate of $3.27?
A beat on EPS would reinforce the company's strong performance trend and could boost investor confidence.
Q2
What guidance will management provide regarding future revenue growth?
Future revenue guidance will be critical for assessing the company's growth trajectory and market positioning.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±3.5%
Why consensus could be wrong
The Street may be underestimating the potential for IQVIA to exceed its revenue targets due to strong demand for its analytics services.
Supporting evidence
Recent performance trends indicate a consistent ability to beat EPS estimates.
The options market suggests heightened expectations for volatility, which could be a sign of upcoming positive news.
Key risk
If revenue growth exceeds $4.5B, it could challenge the current consensus and shift market sentiment.
Pre-commit to what would confirm each case.
This quarter's performance will be closely scrutinized as it could set the tone for the remainder of the year.
Bull confirmed if
An EPS of $3.35 or higher would confirm the bull case, indicating strong operational performance.
Bear confirmed if
An EPS below $3.22 would validate the bear case, raising concerns about the company's growth potential.
What the market is pricing for the move.
Implied Move
±16.03%
Historical Avg
±7.9%
The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.
Options are pricing ±16.0% while IQV has averaged ±7.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
51.6%
Smart-money positioning from the most recent 13F filings.
Institutional
103.51%
of float
Insider
1.09%
of float
Holders
1,558
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
14,549,693 sh · $3.8B
8.84%
-3.2%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If IQVIA beats expectations, history suggests a positive stock reaction, averaging a 2.48% increase the following day.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.
Miss
Should the company miss expectations, history indicates a potential decline, with an average drop of around 4% following misses.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
3
0 buys·3 sells
Members
1
House only
Est. Notional
$17,003.00–$80,000.00
disclosed dollar ranges
Most Active Members
3 trades
The lines on the call that would change the story.
Harris Associates L.P.
12,183,830 sh · $3.1B
7.40%
Flat
Vanguard Capital Management LLC
10,905,053 sh · $2.8B
6.63%
-1.1%
State Street Corporation
7,508,244 sh · $1.9B
4.56%
0.4%
Vanguard Portfolio Management LLC
7,501,993 sh · $1.9B
4.56%
-1.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net selling
Recent Transactions
Traded Sep 14, 2026 · disclosed Sep 25, 2026
$15,001.00–$50,000.00
Traded Sep 8, 2026 · disclosed Sep 25, 2026
$1,001.00–$15,000.00
Traded Sep 3, 2026 · disclosed Sep 25, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.